Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature

Clinical and Experimental Rheumatology

Volumn 26, Issue 4, 2008, Pages 673-679

  Lévy, Lorna ^a   Fautrel, B ^b   Barnetche, T ^a,c   Schaeverbeke, T ^a  

^a HÔPITAL PELLEGRIN   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSERM   (France)

Author keywords

Cardiovascular risk; Meta analysis; Myocardial infarction; Rheumatoid arthritis; Stroke

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT TOOL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; INCIDENCE; MEDLINE; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ARTHRITIS, RHEUMATOID; EUROPE; HUMANS; INCIDENCE; MYOCARDIAL INFARCTION; ODDS RATIO; RISK; STROKE; UNITED STATES;

EID: 52649127888     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. GUILLEMIN F, SARAUX A, GUGGENBUHL P et al: Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis 2005; 64: 1427-30.
2. GABRIEL SE: The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001; 27: 269-81.
3. WONG JB, RAMEY DR, SINGH G: Long-term morbidity, mortality, and economics of rheumatoid arthritis. Arthritis Rheum 2001; 44: 2746-9.
4. BACON PA AND TOWNEND JN: Nails in the coffin: increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritis. Arthritis Rheum 2001; 44: 2707-10.
5. BJORNADAL L, BAECKLUND E, YIN L, GRANATH F, KLARESKOG L, EKBOM A: Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95. J Rheumatol 2002; 29: 906-12.
6. PELTOMAA R, PAIMELA L, KAUTJAINEN H, LEIRISALO-REPO M: Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann Rheum Dis 2002; 61: 889-94.
7. KRISHNAN E, LINGALA VB, SINGH G: Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 2004; 110: 1774-9.
8. WALLBERG-JONSSON S, OHMAN ML, DAHLQVIST SR: Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 1997; 24: 445-51.
9. WELSING PMJ, KIEVIT W, FRANSEN J: The relation of disease activity and methotrexate with the risk of cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis 2005; 64 (Suppl III): 90.
10. Review Manager (RevMan) [Computer program]. Version 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre TCC, 2003.
11. GOODSON N, MARKS J, LUNT M, SYMMONS D: Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis 2005; 64: 1595-601.
12. LINDQVIST E, EBERHARDT K: Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis 1999; 58: 11-4.
13. KVALVIK AG, JONES MA, SYMMONS DP: Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J Rheumatol 2000; 29: 29-37.
14. SINGH G, KRISHNAN E, BHARATHI LINGALA V: Increased case-fatality of acute myocardial infarction in patients with rheumatoid arthritis: data from a large prospective study of 8939 patients followed for 45, 769 person-years. In: EULAR conference. Stockholm 2002.
15. NICOLA PJ, CROWSON CS, MARADIT-KREMERS H et al.: Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 2006; 54:60-7.
16. DEL RINCON ID, WILLIAMS K, STERN MP, FREEMAN GL, ESCALANTE A: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 2737-45.
17. TURESSON C, JARENROS A, JACOBSSON L: Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis 2004; 63: 952-5.
18. GABRIEL SE, CROWSON CS, O'FALLON WM: Comorbidity in arthritis. J Rheumatol 1999; 26: 2475-9.
19. SOLOMON DH, KARLSON EW, RIMM EB et al.: Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003; 107: 1303-7.
20. WOLFE F, FREUNDLICH B, STRAUS WL: Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 2003; 30: 36-40.
21. ERB N, PACE AV, DOUGLAS KM, BANKS MJ, KITAS GD: Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2004; 33: 293-9.
22. YXFELDT A, LUNDBERG V, STEGMAYR B, OHMAN ML, WALLBERG-JONSSON S: Impaired prognosis after acute myocardial infarction and stroke among patients with rheumatoid arthritis. In: EULAR conference. Lisbon; 2003.
23. GONZALEZ-GAYMA,GONZALEZ-JUANATEY C, MARTIN J: Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005; 35: 8-17.
24. GONZALEZ-GAYMA,GONZALEZ-JUANATEY C, MARTIN J: Inflammation and endothelial dysfunction in rheumatoid arthritis. Clin Exp Rheumatol 2006; 24: 115-7.
25. VAUDO G, MARCHESI S, GERLI R et al: Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 2004; 63: 31-5.
26. GONZALEZ-JUANATEY C, TESTA A, GARCIA-CASTELO A et al.: HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 2003; 114: 647-52.
27. MASERI A: Inflammation, atherosclerosis, and ischemic events - exploring the hidden side of the moon. N Engl J Med 1997; 336: 1014-6.
28. ROSS R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
29. SATTAR N, MCCARFY DW, CAPELL H, MCINNES IB: Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003; 108: 2957-63.
30. PASCERI V, YEH ET: A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999; 100: 2124-6.
31. -T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004; 109: 2744-8.
32. WALLBERG-JONSSON S, JOHANSSON H, OHMAN ML, RANTAPAA-DAHLQVIST S: Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol 1999; 26: 2562-71.
33. MARADIT-KREMERS H, NICOLA PJ, CROWSON CS, BALLMAN KV, GABRIEL SE: Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005; 52: 722-32.
34. GONZALEZ-GAYMA,GONZALEZ-JUANATEY C, PINEIRO A, GARCIA-PORRUA C, TESTA A. LLORCA J: High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 1219-23.
35. WEI L, MACDONALD TM, WALKER BR: Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 2004; 141: 764-70.
36. GONZALEZ-GAY MA: Glucocorticoid-related cardiovascular and cerebrovascular events in rheumatic diseases: myth or reality? Arthritis Rheum 2007; 57: 191-2.
37. GRAHAM DJ, CAMPEN D, HUI R et al.: Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 2005; 365: 475-81.
38. SINGH G, WU O, LANGHORNE P, MADHOK R: Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Res Ther 2006; 8: R153.
39. CHOI HK, HERNAN MA, SEEGER JD, ROBINS im, WOLFE F: Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002; 359: 1173-7.
40. HADDY N, SASS C, DROESCH S et al.: IL-6, TNF-alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. Atherosclerosis 2003; 170: 277-83.
41. HURLIMANN D, FORSTER A, NOLL G et al.: Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002; 106: 2184-7.
42. GONZALEZ-JUANATEY C, TESTA A, GARCIA-CASTELO, A, GARCIA-PORRUA C, LLORCA J, GONZALEZ-GAY MA: Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody. Arthritis Rheum 2004; 51: 447-50.
43. GONZALEZ-JUANATEY C, LLORCA J, SANCHEZ-ANDRADE A, GARCIA-PORRUA C, MARTIN J, GONZALEZ-GAY MA: Short-term adalimumab therapy improves endo-thelial function in patients with rheumatoid arthritis refractory to infliximab. Clin Exp Rheumatol 2006; 24: 309-12.